DE60002143D1 - Behandlung autoimmunerkrankungen in säugern - Google Patents

Behandlung autoimmunerkrankungen in säugern

Info

Publication number
DE60002143D1
DE60002143D1 DE60002143T DE60002143T DE60002143D1 DE 60002143 D1 DE60002143 D1 DE 60002143D1 DE 60002143 T DE60002143 T DE 60002143T DE 60002143 T DE60002143 T DE 60002143T DE 60002143 D1 DE60002143 D1 DE 60002143D1
Authority
DE
Germany
Prior art keywords
mammals
treatment
autoimmune diseases
interleukin
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60002143T
Other languages
English (en)
Other versions
DE60002143T2 (de
Inventor
Gomariz Rosa Perez
Martinez Javier Leceta
Mora Mario Delgado
Mora Carmen Martinez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad Complutense de Madrid
Original Assignee
Universidad Complutense de Madrid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES9901235A external-priority patent/ES2160495B1/es
Application filed by Universidad Complutense de Madrid filed Critical Universidad Complutense de Madrid
Application granted granted Critical
Publication of DE60002143D1 publication Critical patent/DE60002143D1/de
Publication of DE60002143T2 publication Critical patent/DE60002143T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2278Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60002143T 1999-06-04 2000-06-02 Behandlung autoimmunerkrankungen in säugern Expired - Fee Related DE60002143T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES9901235 1999-06-04
ES9901235A ES2160495B1 (es) 1998-04-17 1999-06-04 Uso de los peptidos vip y pacap para el tratamiento de enfermedades inflamatorias y autoinmunes en mamiferos.
PCT/ES2000/000197 WO2000074708A1 (es) 1999-06-04 2000-06-02 Metodo para el tratamiento del shock entotoxico y enfermedades inflamatorias y autoinmunes en mamiferos

Publications (2)

Publication Number Publication Date
DE60002143D1 true DE60002143D1 (de) 2003-05-22
DE60002143T2 DE60002143T2 (de) 2004-03-18

Family

ID=8308713

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60002143T Expired - Fee Related DE60002143T2 (de) 1999-06-04 2000-06-02 Behandlung autoimmunerkrankungen in säugern

Country Status (7)

Country Link
EP (1) EP1103270B1 (de)
AT (1) ATE237347T1 (de)
AU (1) AU4927700A (de)
CA (1) CA2345030A1 (de)
DE (1) DE60002143T2 (de)
PT (1) PT1103270E (de)
WO (1) WO2000074708A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1644028B1 (de) 2003-07-14 2009-05-27 mondoBIOTECH AG Substanzen mit biologischer aktivität des vasoaktiven intestinalen peptids für die behandlung von interstitiellen lungenerkrankungen
EP2206715A1 (de) 2004-02-24 2010-07-14 Japan Tobacco, Inc. Annelierte Hetereotetracyclen und ihre Verwendung als HCV polymerase Inhibitoren

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2138561B1 (es) * 1998-04-17 2000-07-01 Univ Madrid Complutense Uso de los peptidos vip y pacap en el tratamiento del shock endotoxico en mamiferos.

Also Published As

Publication number Publication date
CA2345030A1 (en) 2000-12-14
EP1103270B1 (de) 2003-04-16
WO2000074708A1 (es) 2000-12-14
ATE237347T1 (de) 2003-05-15
AU4927700A (en) 2000-12-28
EP1103270A1 (de) 2001-05-30
PT1103270E (pt) 2003-08-29
DE60002143T2 (de) 2004-03-18

Similar Documents

Publication Publication Date Title
IL267381A (en) A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders
EA200100872A1 (ru) Композиция валдекоксиба
DK0682664T3 (da) Forbindelser med både potent calciumantagonist og antioxiderende aktivitet og anvendelse deraf som cytobeskyttende midler
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
CY2607B2 (en) Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanylcyclyse agonists
DE69719798D1 (de) Periphäre verabreichung von glp-1 analogen und derivate zur reguleirung der fettleibigkeit
EA200300171A1 (ru) Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
DE60219887D1 (de) N-(3,-Dimethylindolin-6-yl)ä2-ä(4-pyridylmethyl)aminoü(3-pyridyl)ücarbonsäureamid und dieses enthaltende pharmazeutische Zubereitungen.
EA200200208A1 (ru) Синергитическая композиция
EA200000911A1 (ru) Новые кристаллические формы антивирусного соединения бензимидазола
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
EA200500244A1 (ru) Тетрапропиламмония тетратиомолибдат и родственные соединения для антиангиогенной терапии
SV2002000235A (es) Composiciones farmaceuticas que comprenden valdecoxib
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
DK0489877T3 (da) Antiatherosklerotiske og antithrombotiske 2-amino-6-phenyl-4H-pyran-4-oner
DE60129829D1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
WO2000078795A3 (en) Rufomycins and derivatives thereof useful as inhibitors of multi-drug resistance associated protein-1 (mrp-1)
NZ240481A (en) Aminosulphonyl urea derivatives and pharmaceutical compositions
DE60002143D1 (de) Behandlung autoimmunerkrankungen in säugern
NO961423D0 (no) Oligopeptider avledet fra C-reaktive proteinfragmenter
MXPA05004121A (es) Metodos para tratar la enfermedad de ojo reseco con lantibioticos.
ATE482217T1 (de) Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen
BR0013665A (pt) Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite
PT1207899E (pt) Tratamento da rinite alergica com certas proteinas de ligacao de aminas vasoactivas

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee